Company / Return on Equity (ROE)
Cytosorbents Corp Return on Equity (ROE) History
FY2014-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-101.6%
FY2018
5-year range
-235.2% / -82.4%
FY2014-FY2018
Trend
-23.3%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cytosorbents Corp reports negative total equity of -101.6% in FY2018. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-101.6% in FY2018 with a 3-year CAGR of -5.4%.
Improved from -235.2% to -101.6% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -5.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2018, return on equity (roe) decreased 23.3% year-over-year.
- Peak return on equity (roe) was recorded in FY2017.
- Lowest return on equity (roe) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2018 | -101.6% | -23.3% |
| FY2017 | -82.4% | +65.0% |
| FY2016 | -235.2% | -144.4% |
| FY2015 | -96.3% | +28.3% |
| FY2014 | -134.2% | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026